The health care products project worked to advance policies that would effectively protect consumers from dangerous products and reduce safety risks associated with new innovations in the marketplace. Its efforts focused on diagnostic tests, dietary supplements, over-the-counter drugs, and regenerative medicine. The project concluded in 2022.
In vitro diagnostic (IVD) tests—which use blood, saliva, and other human samples to detect the presence or risk of certain diseases—are a pillar of modern medicine.
Health care organizations are using artificial intelligence (AI)—which the U.S. Food and Drug Administration defines as “the science and engineering of making intelligent machines”—for a growing range of clinical, administrative, and research purposes. This AI software can, for example, help health care providers diagnose diseases, monitor patients’ health, or assist with rote functions such as scheduling patients.
Stem cell products and other regenerative therapies have significant potential to treat traumatic injuries and serious diseases. Although some have earned approval from the Food and Drug Administration, most have not, and many of these unapproved interventions have led to life-threatening infections, chronic pain, and even death.
Americans Support The FDA Tracking Supplement Ingredients
Four in 5 American adults report having used supplements, products that can include vitamins, minerals, plant and animal extracts, hormones, and amino acids. The Food and Drug Administration (FDA) oversees the safety of supplements, and nearly all adults say the agency should have this responsibility.
This video is hosted by YouTube. In order to view it, you must consent to the use of “Marketing Cookies” by updating your preferences in the Cookie Settings link below.
This video is hosted by YouTube. In order to view it, you must consent to the use of “Marketing Cookies” by updating your preferences in the Cookie Settings link below.
